Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Ahemolytic PNH: Clinical Features of a Distinct Phenotype of Paroxysmal Nocturnal Hemoglobinuria

Zehra Tombul, Waled Bahaj, Merve Ozturk, Bhavisha A. Patel, Alina Dulau-Florea, Ahmet Celal Toprak, Ibrahim F. Ibrahim, Weina Chen, Franklin Fuda, Olisaemeka Ogbue, Carmelo Gurnari, Charles Parker, Neal S. Young, Jaroslaw P. Maciejewski, Munevver Duran, Taha Bat

Blood (2023) 142 (Supplement 1): 1352.

https://doi.org/10.1182/blood-2023-186528

Published: 2023

Journal Articles

Thanks for the complement (inhibitor)

Charles Parker

Blood (2011) 118 (17): 4503–4504.

https://doi.org/10.1182/blood-2011-09-377309

Published: 2011

Journal Articles

Characteristics of Laboratory Screening Suggest That Paroxysmal Nocturnal Hemoglobinuria (PNH) Is Perceived Primarily as a Bone Marrow Failure Syndrome Rather Than as a Hemolytic Anemia

Hwee Yong Lim, MBBChBAO, Marjorie Farley, MT(ASCP), Carl Wittwer, MD, PhD, Charles Parker, MD

Blood (2008) 112 (11): 4107.

https://doi.org/10.1182/blood.V112.11.4107.4107

Published: 2008

Journal Articles

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

Charles Parker, Mitsuhiro Omine, Stephen Richards, Jun-ichi Nishimura, Monica Bessler, Russell Ware, Peter Hillmen, Lucio Luzzatto, Neal Young, Taroh Kinoshita, Wendell Rosse, Gerard Socié, for the International PNH Interest Group

Blood (2005) 106 (12): 3699–3709.

https://doi.org/10.1182/blood-2005-04-1717

Published: 2005

Includes: Supplemental data

Journal Articles

Clonal Expansion in Paroxysmal Nocturnal Hemoglobinuria (PNH): Expression of Mutant HMGA2 Suggests That PNH Is a Benign Tumor of the Bone Marrow.

Norimitsu Inoue, MD, PhD, Tomohisa Izui, MD, Yoshiko Murakmai, MD, PhD, Yuichi Endo, PhD, Jun-ichi Nishimura, MD, PhD, Yuzuru Kanakura, MD, PhD, Gabrielle Meyers, MD, Carl Wittwer, MD, PhD, Zhong Chen, MD, William Babcock, MD, Debra Frei-Lahr, MD, Charles Parker, MD, Taroh Kinoshita, PhD

Blood (2005) 106 (11): 3533.

https://doi.org/10.1182/blood.V106.11.3533.3533

Published: 2005

NARROW

Ahemolytic PNH: Clinical Features of a Distinct Phenotype of Paroxysmal Nocturnal Hemoglobinuria

Thanks for the complement (inhibitor)

Characteristics of Laboratory Screening Suggest That Paroxysmal Nocturnal Hemoglobinuria (PNH) Is Perceived Primarily as a Bone Marrow Failure Syndrome Rather Than as a Hemolytic Anemia

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

Clonal Expansion in Paroxysmal Nocturnal Hemoglobinuria (PNH): Expression of Mutant HMGA2 Suggests That PNH Is a Benign Tumor of the Bone Marrow.

Email alerts

ASH Publications

American Society of Hematology

Ahemolytic PNH: Clinical Features of a Distinct Phenotype of Paroxysmal Nocturnal Hemoglobinuria

Thanks for the complement (inhibitor)

Characteristics of Laboratory Screening Suggest That Paroxysmal Nocturnal Hemoglobinuria (PNH) Is Perceived Primarily as a Bone Marrow Failure Syndrome Rather Than as a Hemolytic Anemia

Diagnosis and management of paroxysmal nocturnal hemoglobinuria

Clonal Expansion in Paroxysmal Nocturnal Hemoglobinuria (PNH): Expression of Mutant HMGA2 Suggests That PNH Is a Benign Tumor of the Bone Marrow.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only